AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06312904 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Local infiltration anesthesia
Description: After cardiac surgery, the anesthesiologist will use 3mg/kg of 0.375% ropivacaine to conduct local infiltration anesthesia.
Study NCT05706012 — intervention group
Intervention type: OTHER
Intervention: Survey
Description: Online survey questioning the current clinical practice on long-term antithrombotic management of AMI in SBS patients
Study NCT04803799 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Training Programme
Description: Cognitive-motor dual task exercises corresponding to associations between different motor tasks and different cognitive tasks.
Study NCT05192798 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Albumin-Bound Paclitaxel
Description: Albumin-bound paclitaxel is one of the standard first-line regimens for relapsed or metastatic triple-negative breast cancer.
Study NCT05192798 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Albumin-Bound Paclitaxel
Description: Albumin-bound paclitaxel is one of the standard first-line regimens for relapsed or metastatic triple-negative breast cancer.
Study NCT05192798 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apatinib Mesylate
Description: Apatinib mesylate is an orally administered small-molecule vascular endothelial growth factor receptor-2 (VEGFR-2) tyrosine kinase inhibitor (TKI).
Study NCT05192798 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Bevacizumab is a humanized anti-VEGF monoclonal antibody once approved by FDA for treatment of metastatic breast cancer in combination with chemotherapy.
Study NCT05564871 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: occupation-based teleintervention
Description: Intervention protocol will include 12 weekly based on the principles of the CO-OP approach. The intervention will focus on solving problems in the participant's daily life and implementing strategies in accordance with the goals set according to the COPM (Law et al., 2017). In the research group, the intervention will be carried out through videoconference sessions between an occupational therapist located at one of the child development units and the participant and their parents who are at home. The control group will receive a weekly session of CO-OP intervention in-person in one of the child development units.
Study NCT04858906 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: McGrath laryngoscope
Description: The patients in this group will be evaluated and intubated with McGrath laryngoscope (angulated videolaryngoscope).
Study NCT04858906 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: C-MAC D-blade laryngoscope
Description: The patients in this group will be evaluated and intubated with C-MAC D-blade laryngoscope (hyperangulated videolaryngoscope).
Study NCT05295095 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: positive pressure during extubation procedure
Description: positive pressure during extubation procedure
Study NCT05019157 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telerehabilitation group
Description: Participants will undertake the first three training sessions in the outpatient clinic for familiarization with the training modalities, the wearable sensors and the data uploading. Afterwards, the participants will proceed with the telerehabilitation program at their homes. The participants will be lent the wearable sensors and will undergo an exercise - based program 3 times/week, comprising of 10' warm up exercises, 40' aerobic, resistance, balance exercises and 10' cool down.Training sessions will be monitored, in real time, by the study investigator. Participants should upload the recorded data to Polar Flow web platform after every training session and should visit the outpatient clinic every month to upload the accelerometry's recorded data to a secure personal computer) application. Educational and informational videoconferences will be held every week for upright training exercise sessions, physical activity counseling, diet/nutritional and smoking cessation counseling.
Study NCT05019157 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Centre - based rehabilitation group
Description: Participants will attend an exercise - based cardiac rehabilitation program at the outpatient clinic's facilities under the supervision of cardiac rehabilitation specialized staff. The participants will receive an individually tailored training program on a treadmill or a cycle ergometer. Total training attendance rate will be documented by the cardiac rehabilitation centre staff. Patients will be instructed to wear a tri - axial accelerometer during the entire 12 weeks study period. Participants should upload recorded data to the local server every month. Educational videoconferences will be held every week for physical activity counseling, diet/nutritional and smoking cessation counseling.
Study NCT05804279 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BPDO-1603
Description: donepezil/mematine
Study NCT05804279 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: BPDO-1603
Description: donepezil/mematine
Study NCT05933187 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment A: Emraclidine 30mg IR tablets (reference)
Description: IR oral tablets
Study NCT05933187 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment B: Emraclidine 30mg IR test tablets 1
Description: IR oral tablets
Study NCT05933187 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment C: Emraclidine 30mg IR test tablets 2
Description: IR oral tablets
Study NCT05933187 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment D: Emraclidine 30mg IR test tablets 3
Description: IR oral tablets
Study NCT06418854 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire
Description: Adapted design questionnaire to estimate the vaccine hesitancy specifically for dengue vaccine
Study NCT06243471 — intervention group
Intervention type: PROCEDURE
Intervention: Minimally invasive procedures for the Hallux Abductus Valgus.
Description: Minimally invasive procedures for the Hallux Abductus Valgus
Study NCT06243471 — intervention group
Intervention type: PROCEDURE
Intervention: Minimally invasive procedures for the Hallux Abductus Valgus and a zig-zag tenotomy for the extensus hallux longus.
Description: Minimally invasive procedures for the Hallux Abductus Valgus and a zig-zag tenotomy for the extensus hallux longus.
Study NCT05638893 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo Tablet
Description: Placebo (tablet/12hr) + celecoxib (200mg/day) for three months.
Study NCT05638893 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin Hcl 500Mg Tab
Description: Metformin (500mg/12hr) + celecoxib (200mg/day) for three months.
Study NCT05296525 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: GDA-201
Description: NAM-expanded allogeneic NK cells
Study NCT05606887 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Wearable Device and Ecological Momentary Assessments
Description: The intervention will consist of three components:~1. Completion of brief text-message based surveys 2-3 times per week~2. Wearing a wrist-based wearable device to generate individual data insights on physiological data related to stress and well-being, including heart rate variability, stress scores, and sleep quality~3. Individual biweekly reports of survey response trends and curated resources intended to support participant well-being
Study NCT05033808 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epirubicin
Description: Epirubicin is given once over 15 Minutes via a central line
Study NCT05033808 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: NaCl is given once over 15 Minutes via a central line
Study NCT05185544 — intervention group
Intervention type: OTHER
Intervention: Neoadjuvant pemetrexed and cisplatin chemotherapy
Description: neoadjuvant pemetrexed and cisplatin chemotherapy in patients with lung adenocarcinoma
Study NCT05514821 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Beet It Sport Shot
Description: Acute supplementation with 140 ml Beet It Sport Shots, James White Ltd, containing \~400mg dietary nitrate
Study NCT05514821 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Beet It Sport Shot Placebo
Description: Acute supplementation with 140 ml Beet It Sport Shots Placebo, James White Ltd, in which the nitrate has been removed via an ion exchange resin, containing \~ 0 mg dietary nitrate
Study NCT04746378 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Computed Tomography, CSD
Description: Measurement of the stone burden by cumulative stone diameter, the sum of linear longest diameters of all the stones to be treated within one patient as measured on the CT or by additional rendering software
Study NCT04746378 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Computed Tomography, SA
Description: Measurement of the stone burden by surface area, the sum of surface areas of all the stones to be treated within one patient as measured on the CT or by additional rendering software
Study NCT04746378 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Computed Tomography, 3D
Description: Measurement of the stone burden by volume of all the stones to be treated within one patient, as measured on the CT or by additional rendering software
Study NCT04140279 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Latanoprostene Bunod
Description: Ophthalmic solution
Study NCT04140279 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Ophthalmic solution, no active ingredient.
Study NCT05515120 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rivaroxaban 20 MG [Xarelto]
Description: It was adopted an equal allocation of patients to each treatment (i.e., 1:1 randomization)
Study NCT05515120 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Aspirin 300mg
Description: It was adopted an equal allocation of patients to each treatment (i.e., 1:1 randomization)
Study NCT05515120 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Acenocoumarol Oral Tablet
Description: It was adopted an equal allocation of patients to each treatment (i.e., 1:1 randomization)
Study NCT04864483 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Meal timing in relation to time of starting the fast
Description: as described
Study NCT05917041 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SAT-001(Software as Medical Device)
Description: Using SAT-001 application for 48 weeks and wearing glasses or not
Study NCT04980950 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Impact Oral Nestlé Health Science, Cubitan® Nutricia, Nutridrink® Nutricia, Resource 2.0 Nestlé Health Science
Description: Gastric and colorectal cancer patients will receive 1 bottle of immunonutrition or standard nutrition for 10 days. The aims of this study is to assess the effects of these immunonutrition on gut microbiota, intestinal permeability as well as inflammation of intestines in gastric and colorectal cancer patients.
Study NCT04980950 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Impact Oral Nestlé Health Science, Cubitan® Nutricia, Nutridrink® Nutricia, Resource 2.0 Nestlé Health Science
Description: Gastric and colorectal cancer patients will receive 1 bottle of immunonutrition or standard nutrition for 10 days. The aims of this study is to assess the effects of these immunonutrition on gut microbiota, intestinal permeability as well as inflammation of intestines in gastric and colorectal cancer patients.
Study NCT05117255 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Negative Emotions and Addiction Tools Program (NEAT)- Cognitive Behavioral Therapy
Description: The program provides simplified clinical, learning and neuroscience-based education about the vicious cycle in which negative affect serves to motivate drinking, which, in turn, worsens negative affect. Participants also learn how each of three skills (breathing control, cognitive restructuring, problem solving) was designed to disrupt a specific element of the vicious cycle that includes physiological, psychological and behavioral processes.
Study NCT05117255 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Progressive Muscle Relaxation Training (PMRT)
Description: PMRT is a standard stress management coping skill that entails tensing and releasing specified muscle groups to obtain deep muscle relaxation.
Study NCT05313126 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: sterile insect technique (TIS)
Description: Sterile male Aedes albopictus mosquitos are released in the area/neighborhood
Study NCT05192538 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Endoscopic endoloop pre-test treatment
Description: A novel endoloop was inserted into the gastric cardia by forceps through the single-channel endoscopy. After adjustment of the endoloop's location and angle, it was anchored onto the edge of the gastric cardia with clip and another 1 or 2 clips were inserted to hold the opposite side of endoloop at about 1/2 circumference. Then the hook was connected with the endoloop, which was tighted by slight pulling together of all the clips.
Study NCT05570474 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Protein drink supplementation
Description: Daily drink containing 20 grams of whey protein, dissolved in 200mL water.
Study NCT05570474 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Daily placebo drink
Study NCT04691999 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intermittent Fasting
Description: 16-18 hour fasting period four times per week
Study NCT05097014 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: CHF5993
Description: Pressurized metered dose inhaler (pMDI) 2 inhalations bid
Study NCT05097014 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: CHF1535
Description: Pressurized metered dose inhaler (pMDI) 2 inhalations bid
Study NCT05097014 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Matched placebo
Description: Pressurized metered dose inhaler (pMDI) 2 inhalations bid
Study NCT05033652 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: WARNING KD
Description: Within 48h of detecting an abnormal creatinemia value (GFR\<30 or AKIN2 and AKIN3), the biology laboratory will communicate the patient's information to the WARNING KD team. This team consists of one nephrologist and one clinical pharmacist who will trigger the initial management in the department and then, if the patient has a persistant warning signal during hospitalization, define the patient's course of treatment for discharge. Patients requiring special care will be oriented towards a nephrologist and the patient's GP will be alerted to the benefit of addressing the patient to a nephrologist for multidisciplinary management with a therapeutic project according to the recommendations for good therapeutic practices.
Study NCT05426759 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pulsed Field Ablation of epicardial Ganglionated Plexi.
Description: Using Pulsed Field Ablation (PFA), delivered via an epicardial catheter, to selectively ablate the ganglionated plexi (GP) on the epicardial surface of the heart.
Study NCT04910503 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone intravitreal implant
Description: Implant every 4 months if necessary
Study NCT04910503 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluocinolone Acetonide Intravitreal Implant
Description: Implantation
Study NCT04872881 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Endotracheal Tube Insertion
Description: ETT will be repositioned with direct laryngoscopy (ETT cuff will be inflated just above the vocal cords)
Study NCT04872881 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Laryngeal Mask Insertion
Description: After selecting the appropriate LMA size for the patient, the ET Tube will be removed and the LMA will be inserted.
Study NCT04872881 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Fiberoptic Bronchoscopy
Description: After the patients' airway is established, the trachea and the process area will be displayed by the physician.~The success rate will be increased by performing the procedure with fiberoptic bronchoscopy.
Study NCT04872881 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Radial Artery Monitoring
Description: The radial artery will be cannulated. Hemodynamic monitoring and blood gas analysis will be done in this way.
Study NCT04872881 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Anteroposterior chest x-ray
Description: When the tracheostomy cannula is placed and the patient is ventilated, the procedure will be terminated and confirmed with anteroposterior chest x-ray.
Study NCT04872881 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Arterial Blood Gas Analyses
Description: Hypoxia, acidosis and carbon dioxide increase will be followed
Study NCT04872881 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol Fresenius
Description: 2mg/kg of propofol 2% injectable solution was given and propofol infusion at the dose of 6 mg/kg/hour will be started.
Study NCT04872881 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rocuronium
Description: 0.6 mg/kg of rocuronium 50mg/5ml injectable solution was given.
Study NCT04872881 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fentanyl
Description: 1mcg/kg fentanyl of 0.5 mg/10ml injectable solution was given.
Study NCT04733781 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tumescent Lidocaine and Epinephrine
Description: Subcutaneous injection of a relatively large volume (125ml to 250ml) of a relatively dilute solution of lidocaine (1gm/L) and epinephrine (1mg/L or 2mg/L).
Study NCT05908825 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Vitamin C with AHA Exfoliative Serum
Description: Catalyst is a novel skincare product comprised of low concentrations of multiple hydroxy acids and will be randomly assigned as Product A or Product B to be applied to one side of the face.
Study NCT05908825 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Placebo serum
Description: Placebo serum will be randomly assigned as Product A or Product B to be applied to one side of the face.
Study NCT04786951 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Attentional Bias Modification Training
Description: Combine usual cognitive-behavioral treatment (CBT) sessions with additional five VR-based body-exposure therapy sessions and five sessions of Attentional Bias Modification Training.
Study NCT04786951 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: VR-based body exposure
Description: Combine usual cognitive-behavioral treatment (CBT) sessions with additional five VR-based body-exposure therapy sessions
Study NCT04786951 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive-behavioral therapy
Description: Usual cognitive-behavioral treatment (CBT) sessions.
Study NCT04786951 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy
Description: Usual cognitive-behavioral treatment (CBT) sessions.
Study NCT04572022 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Step wise post-procedure mobile health shared rehabilitation teaching video instructions modules (as per fracture type)
Description: Intervention group receive proximal humerus fracture standard care with additional mobile health shared step-wise rehabilitation teaching video instructions modules (as per fracture type). Classic Blue tooth technology will be utilized for teaching information sharing from doctor to the patient.
Study NCT04894162 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Questionnaire
Description: Consecutive, eligible inpatients in a participating specialist palliative care unit will be invited to participate in the research: those who wish to participate will complete a research questionnaire about research preferences.
Study NCT05279209 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: catheter-directed sclerotherapy
Description: Ovarian endometrioma is targeted under transvaginal/transabdominal ultrasound. A guidewire is inserted to the lesion and is exchanged for a catheter. The cystic content is thoroughly aspirated and then sclerotherapy is performed by injecting 99% ethanol.
Study NCT05279209 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: surgical resection
Description: Surgical resection of the ovarian endometrioma is performed under general anesthesia. To preserve the residual ovarian function, enucleation is the primary surgical technique.
Study NCT05908955 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: PVI
Description: pulmonary vein isolation
Study NCT05908955 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: PVI+ quantitative SVCI
Description: pulmonary vein isolation and superior vena cava isolation guided by quantitative ablation index
Study NCT04895072 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard group
Description: Ultrasound-guided ESP block with 20 mL %0.375 bupivacaine will be administered at a standard injection rate.
Study NCT04895072 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Long group
Description: Ultrasound-guided ESP block with 20 mL %0.375 bupivacaine will be administered at a long injection rate.
Study NCT06262854 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Calcium-sulphate granules with tobramicina+vancomicina
Description: Local calcium-sulphate antibiotics deliver for the treatment of diabetic foot osteomyelitis